Status:
COMPLETED
Shared Decision-Making Structured Team Model for Critical Maternal Care in OB-GYN ICU
Lead Sponsor:
Ying Wang
Conditions:
Critical Illness
Pregnant Women
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
A randomized controlled trial was conducted with 100 critically ill pregnant women admitted to our hospital's obstetrics ICU between January 2023 and December 2024. Participants were allocated via ran...
Eligibility Criteria
Inclusion
- Meeting diagnostic criteria for critical obstetric conditions:
- Amniotic fluid embolism
- Postpartum hemorrhage
- Emergency cesarean section was performed, etc
- Age ≥18 years
- Gestational age \>20 weeks
- Patient's family/legal representative capable of normal communication and providing signed informed consent
Exclusion
- Pre-existing primary hematologic disorders:
- Fetal congenital anomalies confirmed by prenatal imaging
- Active malignant tumors (except carcinoma in situ)
- Severe organ dysfunction:
- Altered mental status (GCS ≤12) or documented psychiatric disorders
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06930469
Start Date
January 1 2023
End Date
February 1 2025
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nantong First People's Hospital
Nantong, Jiangsu, China, 226000